Ophthalmologic Approach to Chemical Burns Treatment & Management

  • Author: J Bradley Randleman, MD; Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: Feb 7, 2011
 

Medical Care

Treatment of chemical injuries to the eye requires medical and surgical intervention, both acutely and in the long term, for maximal visual rehabilitation.

Regardless of the underlying chemical involved, common goals of management include the following: (1) removing the offending agent, (2) promoting ocular surface healing, (3) controlling inflammation, (4) preventing infection, and (5) controlling IOP.

Remove inciting chemical (irrigation)

Immediate copious irrigation remains the single most important therapy for treating chemical injuries. If available, the eye should be anesthetized prior to irrigation.

Ideally, the eye should be irrigated with a sterile balanced buffered solution, such as normal saline solution or Ringer's lactate solution. However, immediate irrigation with even plain tap water is preferred without waiting for the ideal fluid.

The irrigation solution must contact the ocular surface. This is best achieved with a special irrigating tubing (eg, Morgan lens) or a lid speculum. Irrigation should be continued until the pH of the ocular surface is neutralized, usually requiring 1-2 liters of fluid.

Promote ocular surface (epithelial) healing

Once the inciting chemical has been completely removed, epithelial healing can begin. Chemically injured eyes have a tendency to poorly produce adequate tears; therefore, artificial tear supplements play an important role in healing.

Ascorbate plays a fundamental role in collagen remodeling, leading to an improvement in corneal healing.

Placement of a therapeutic bandage contact lens until the epithelium has regenerated can be helpful in some patients.[10]

Amniotic membrane transplant in eyes with acute ocular burns promotes faster healing of epithelial defect in patients with moderate grade burns.[11] No long-term advantage of amniotic membrane transplant is evident when compared with medical and mechanical release of adhesions in terms of final visual outcome appearance of symblepharon and corneal vascularis in a controlled clinical setting.

Control inflammation

Inflammatory mediators released from the ocular surface at the time of injury cause tissue necrosis and attract further inflammatory reactants.

This robust inflammatory response not only inhibits reepithelialization but also increases the risk of corneal ulceration and perforation.

Controlling inflammation with topical steroids can help break this inflammatory cycle.

Citrate both promotes corneal wound healing and inhibits PMNs via calcium chelation. One study showed better visual outcomes using both ascorbate and citrate compared to controls in chemically injured eyes.[12]

Acetylcysteine (10% or 20%) can inhibit collagenase to reduce corneal ulceration, yet its clinical use is currently controversial.

Prevent infection

When the corneal epithelium is absent, the eye is susceptible to infection.

Prophylactic topical antibiotics are warranted during the initial treatment stages.

Control IOP

The use of aqueous suppressants is advocated to reduce IOP secondary to chemical injuries, both as an initial therapy and during the later recovery phase, if IOP is high (>30 mm Hg).

Control pain

Severe chemical burns can be extremely painful.

Ciliary spasm can be managed with the use of cycloplegic agents; however, oral pain medication may be necessary initially to control pain.

Next

Surgical Care

  • Remove inciting chemical
    • After instilling topical anesthesia, sweep the fornices with a moist sterile cotton swab to remove any retained foreign material.
    • This technique is especially important when particulate matter (eg, plaster) is responsible for the injury.
  • Promote ocular surface healing
    • Debride necrotic conjunctival/corneal tissue
    • Temporary amniotic membrane patching[13]
    • Limbal stem cell transplant
    • Cultivated corneal epithelial stem cell sheet transplantation[14]
    • Lysis of conjunctival symblepharon. Adhesions are a later finding, and they can be managed with repeated lysis using a glass rod or a sterile cotton swab.
  • Prevent infection: Cyanoacrylate tissue adhesive may be applied for the treatment of small corneal perforations.
  • Visual rehabilitation[15]
    • Penetrating keratoplasty with or without cataract extraction
    • Keratoprosthesis
  • Control IOP: Glaucoma filtering surgery or aqueous tube shunt placement may be used for cases of increased IOP refractory to medical management.
Previous
Next

Consultations

In most instances, patients present to nonophthalmologists for their immediate care. At a minimum, patients with mild chemical injuries should have follow-up care arranged with an ophthalmologist. Any patient with a moderate-to-serious injury should be immediately evaluated and followed accordingly by an ophthalmologist. Other medical personnel may be needed as determined by the extent of the extraocular injuries sustained.

Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

J Bradley Randleman, MD  Associate Professor, Department of Ophthalmology, Section of Cornea, External Disease and Refractive Surgery, Emory University School of Medicine; Director of Cornea, External Disease and Refractive Surgery Fellowship, Emory University; Physician Member, Section of Ophthalmology, The Emory Clinic

J Bradley Randleman, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Cornea Society, and International Society of Refractive Surgery

Disclosure: Nothing to disclose.

Coauthor(s)

Alok S Bansal, MD  Resident Physician, Emory Eye Center

Alok S Bansal, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Association for Research in Vision and Ophthalmology, and International Society of Refractive Surgery

Disclosure: Nothing to disclose.

Evan S Loft  MD, Clinical Assistant Professor, Department of Ophthalmology, Emory University

Evan S Loft is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, American Society of Cataract and Refractive Surgery, Association for Research in Vision and Ophthalmology, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Geoffrey Broocker, FACS, MD  Walthour-DeLaPerriere Professor of Ophthalmology, Department of Ophthalmology, Emory University School of MedicineChief of Service, Ophthalmology, Grady Memorial Hospital

Geoffrey Broocker, FACS, MD is a member of the following medical societies: American College of Surgeons

Disclosure: Nothing to disclose.

Specialty Editor Board

Fernando H Murillo-Lopez, MD  Senior Surgeon, Unidad Privada de Oftalmologia CEMES

Fernando H Murillo-Lopez, MD is a member of the following medical societies: American Academy of Ophthalmology

Disclosure: Nothing to disclose.

Simon K Law, MD, PharmD  Associate Professor of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology

Disclosure: Nothing to disclose.

Christopher J Rapuano, MD  Professor, Department of Ophthalmology, Jefferson Medical College of Thomas Jefferson University; Director of the Cornea Service, Co-Director of Refractive Surgery Department, Wills Eye Institute

Christopher J Rapuano, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Contact Lens Association of Ophthalmologists, Cornea Society, Eye Bank Association of America, International Society of Refractive Surgery, and Pan-American Association of Ophthalmology

Disclosure: Allergan Honoraria Speaking and teaching; Allergan Consulting fee Consulting; Alcon Honoraria Speaking and teaching; Inspire Honoraria Speaking and teaching; RPS Ownership interest Other; Vistakon Honoraria Speaking and teaching; EyeGate Pharma Consulting; Inspire Consulting fee Consulting; Bausch & Lomb Honoraria Speaking and teaching; Bausch & Lomb Consulting fee Consulting

Lance L Brown, OD, MD  Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

References
  1. Merle H, Gerard M, Schrage N. [Ocular burns]. J Fr Ophtalmol. Sep 2008;31(7):723-34. [Medline].

  2. Hodge C, Lawless M. Ocular emergencies. Aust Fam Physician. Jul 2008;37(7):506-9. [Medline].

  3. Spector J, Fernandez WG. Chemical, thermal, and biological ocular exposures. Emerg Med Clin North Am. Feb 2008;26(1):125-36, vii. [Medline].

  4. Pfister DA, Pfister RR. Acid injuries of the eye. Fundamentals of Cornea and External Disease. Cornea. Vol 2. 2005:1277-84.

  5. Pfister RR, Pfister DA. Alkali injuries of the eye. In: Fundamentals of Cornea and External Disease. Cornea. Vol 2. 2005:1285-93.

  6. Xiang H, Stallones L, Chen G, Smith GA. Work-related eye injuries treated in hospital emergency departments in the US. Am J Ind Med. Jul 2005;48(1):57-62. [Medline].

  7. Morgan SJ. Chemical burns of the eye: causes and management. Br J Ophthalmol. Nov 1987;71(11):854-7. [Medline].

  8. Klein R, Lobes LA Jr. Ocular alkali burns in a large urban area. Ann Ophthalmol. Oct 1976;8(10):1185-9. [Medline].

  9. Wagoner MD, Kenyon KR. Chemical injuries of the eye. Clinical Practice. In: Albert, Jakobiec, eds. Principles and Practice of Ophthalmology. Vol 2. 2000:943-59.

  10. Kheirkhah A, Johnson DA, Paranjpe DR, Raju VK, Casas V, Tseng SC. Temporary sutureless amniotic membrane patch for acute alkaline burns. Arch Ophthalmol. Aug 2008;126(8):1059-66. [Medline].

  11. Tandon R, Gupta N, Kalaivani M, et al. Amniotic membrane transplantation as an adjunct to medical therapy in acute ocular burns. Br J Ophthalmol. Feb 2011;95(2):199-204. [Medline].

  12. Brodovsky SC, McCarty CA, Snibson G, et al. Management of alkali burns : an 11-year retrospective review. Ophthalmology. Oct 2000;107(10):1829-35. [Medline].

  13. Kheirkhah A, Johnson DA, Paranjpe DR, Raju VK, Casas V, Tseng SC. Temporary sutureless amniotic membrane patch for acute alkaline burns. Arch Ophthalmol. Aug 2008;126(8):1059-66. [Medline].

  14. Kawashima M, Kawakita T, Satake Y, Higa K, Shimazaki J. Phenotypic study after cultivated limbal epithelial transplantation for limbal stem cell deficiency. Arch Ophthalmol. Oct 2007;125(10):1337-44. [Medline].

  15. Tuft SJ, Shortt AJ. Surgical rehabilitation following severe ocular burns. Eye. Jan 23 2009;[Medline].

  16. Dua HS, King AJ, Joseph A. A new classification of ocular surface burns. Br J Ophthalmol. Nov 2001;85(11):1379-83. [Medline].

Previous
Next
 
Alkali burn. Note the severe conjunctival reaction and stromal opacification blurring iris details inferiorly.
Severe chemical injury with early corneal neovascularization.
Complete cicatrization of the corneal surface following chemical injury.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.